Disease associated variation - GWASdb Chr Pos SNP ID(dbSNP 142) Ref Alt Ori SNP ID P-value Drug Name Drug Anno GWAS Trait HPO ID DO ID AA Type Trait or Drug 7 72856269 rs2240466 G A rs2240466 3.29E-08 CHOLESTEROL LIPOPROTEINS|TRIGLYCERIDES Lipid levels HPOID:0003119 DOID:3146|DOID:1287|DOID:9970 C intron GWASdb_drug 7 72856269 rs2240466 G A rs2240466 1.00E-06 CAFFEINE CYTOCHROME P-450 CYP1A2|RECEPTORS, ARYL HYDROCARBON Caffeine consumption HPOID:0000707 NA C intron GWASdb_drug 7 72856269 rs2240466 G A rs2240466 2.98E-09 URIC ACID GLUCOSE|INHIBINS Urate levels HPOID:0000079 DOID:13189 C intron GWASdb_drug 7 72856430 rs1178979 T C rs1178979 6.90E-05 PRAVASTATIN|CHOLESTEROL|ATORVASTATIN|SIMVASTATIN PYRROLES|LIPIDS|HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS|HEPTANOIC ACIDS Response to statin therapy HPOID:0001677 DOID:3393|DOID:423|DOID:1936 G intron GWASdb_drug 7 72856430 rs1178979 T C rs1178979 9.80E-12 URIC ACID GLUCOSE|INHIBINS Urate levels HPOID:0000079 DOID:13189 G intron GWASdb_drug 7 72857049 rs1178977 A G rs1178977 6.90E-05 PRAVASTATIN|CHOLESTEROL|ATORVASTATIN|SIMVASTATIN PYRROLES|LIPIDS|HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS|HEPTANOIC ACIDS Response to statin therapy HPOID:0001677 DOID:3393|DOID:423|DOID:1936 G intron GWASdb_drug 7 72857049 rs1178977 A G rs1178977 1.00E-12 URIC ACID GLUCOSE|INHIBINS Urate levels HPOID:0000079 DOID:13189 G intron GWASdb_drug 7 72864869 rs714052 A G rs714052 1.58E-10 CHOLESTEROL LIPOPROTEINS|TRIGLYCERIDES Lipid levels HPOID:0003119 DOID:3146|DOID:1287|DOID:9970 T intron GWASdb_drug 7 72864869 rs714052 A G rs714052 2.98E-08 CHOLESTEROL LIPOPROTEINS|TRIGLYCERIDES Lipid levels HPOID:0003119 DOID:3146|DOID:1287|DOID:9970 T intron GWASdb_drug 7 72864869 rs714052 A G rs714052 3.00E-07 URIC ACID BIOLOGICAL MARKERS Blood cell counts and other traits HPOID:0011873|HPOID:0011902|HPOID:0004352|HPOID:0004297|HPOID:0004348|HPOID:0100767|HPOID:0001909|HPOID:0002665|HPOID:0010876|HPOID:0003138|HPOID:0000077|HPOID:0003107 DOID:74|DOID:526|DOID:5844 T intron GWASdb_drug 7 72864869 rs714052 A G rs714052 3.30E-07 URIC ACID BIOLOGICAL MARKERS Blood cell counts and other traits HPOID:0011873|HPOID:0011902|HPOID:0004352|HPOID:0004297|HPOID:0004348|HPOID:0100767|HPOID:0001909|HPOID:0002665|HPOID:0010876|HPOID:0003138|HPOID:0000077|HPOID:0003107 DOID:74|DOID:526|DOID:5844 T intron GWASdb_drug 7 72864869 rs714052 A G rs714052 1.24E-06 CAFFEINE CYTOCHROME P-450 CYP1A2|RECEPTORS, ARYL HYDROCARBON Caffeine consumption HPOID:0000707 NA T intron GWASdb_drug 7 72864869 rs714052 A G rs714052 3.68E-09 URIC ACID GLUCOSE|INHIBINS Urate levels HPOID:0000079 DOID:13189 T intron GWASdb_drug 7 72877166 rs2074755 T C rs2074755 3.51E-06 URIC ACID BIOLOGICAL MARKERS|LIPIDS Cardiovascular disease HPOID:0001626 DOID:1287 A intron GWASdb_drug 7 72877166 rs2074755 T C rs2074755 1.61E-09 URIC ACID GLUCOSE|INHIBINS Urate levels HPOID:0000079 DOID:13189 A intron GWASdb_drug 7 72878645 rs12056034 A G rs12056034 2.32E-09 URIC ACID GLUCOSE|INHIBINS Urate levels HPOID:0000079 DOID:13189 A intron GWASdb_drug 7 72885810 rs6976930 G A rs6976930 8.00E-05 PRAVASTATIN|CHOLESTEROL|ATORVASTATIN|SIMVASTATIN PYRROLES|LIPIDS|HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS|HEPTANOIC ACIDS Response to statin therapy HPOID:0001677 DOID:3393|DOID:423|DOID:1936 A intron GWASdb_drug 7 72885810 rs6976930 G A rs6976930 3.14E-11 URIC ACID GLUCOSE|INHIBINS Urate levels HPOID:0000079 DOID:13189 A intron GWASdb_drug 7 72904810 rs17145713 C T rs17145713 8.00E-05 PRAVASTATIN|CHOLESTEROL|ATORVASTATIN|SIMVASTATIN PYRROLES|LIPIDS|HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS|HEPTANOIC ACIDS Response to statin therapy HPOID:0001677 DOID:3393|DOID:423|DOID:1936 C intron GWASdb_drug 7 72904810 rs17145713 C T rs17145713 2.16E-11 URIC ACID GLUCOSE|INHIBINS Urate levels HPOID:0000079 DOID:13189 C intron GWASdb_drug 7 72911843 rs13244268 T C rs13244268 2.27E-09 URIC ACID GLUCOSE|INHIBINS Urate levels HPOID:0000079 DOID:13189 T intron GWASdb_drug 7 72934510 rs7811265 A G rs7811265 5.90E-05 PRAVASTATIN|CHOLESTEROL|ATORVASTATIN|SIMVASTATIN PYRROLES|LIPIDS|HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS|HEPTANOIC ACIDS Response to statin therapy HPOID:0001677 DOID:3393|DOID:423|DOID:1936 G intron GWASdb_drug 7 72934510 rs7811265 A G rs7811265 2.17E-10 URIC ACID GLUCOSE|INHIBINS Urate levels HPOID:0000079 DOID:13189 G intron GWASdb_drug 7 72856269 rs2240466 G A rs2240466 1.00E-12 Triglycerides HPOID:0003119 DOID:3393|DOID:3146|DOID:2349 C intron GWASdb_trait 7 72856269 rs2240466 G A rs2240466 3.29E-08 Lipid levels HPOID:0003119 DOID:3146|DOID:1287|DOID:9970 C intron GWASdb_trait 7 72856269 rs2240466 G A rs2240466 1.00E-06 Caffeine consumption HPOID:0000707 NA C intron GWASdb_trait 7 72856269 rs2240466 G A rs2240466 9.96E-12 Metabolite levels HPOID:0001939 DOID:655 C intron GWASdb_trait 7 72856269 rs2240466 G A rs2240466 2.98E-09 Urate levels HPOID:0000079 DOID:13189 C intron GWASdb_trait 7 72856430 rs1178979 T C rs1178979 6.90E-05 Response to statin therapy HPOID:0001677 DOID:3393|DOID:423|DOID:1936 G intron GWASdb_trait 7 72856430 rs1178979 T C rs1178979 2.84E-08 Protein C levels HPOID:0003256 DOID:3756 G intron GWASdb_trait 7 72856430 rs1178979 T C rs1178979 2.00E-12 Triglycerides HPOID:0003119 DOID:3393|DOID:3146|DOID:2349 G intron GWASdb_trait 7 72856430 rs1178979 T C rs1178979 4.26E-13 Metabolite levels HPOID:0001939 DOID:655 G intron GWASdb_trait 7 72856430 rs1178979 T C rs1178979 9.80E-12 Urate levels HPOID:0000079 DOID:13189 G intron GWASdb_trait 7 72857049 rs1178977 A G rs1178977 6.90E-05 Response to statin therapy HPOID:0001677 DOID:3393|DOID:423|DOID:1936 G intron GWASdb_trait 7 72857049 rs1178977 A G rs1178977 2.83E-08 Protein C levels HPOID:0003256 DOID:3756 G intron GWASdb_trait 7 72857049 rs1178977 A G rs1178977 8.96E-11 Metabolite levels HPOID:0001939 DOID:655 G intron GWASdb_trait 7 72857049 rs1178977 A G rs1178977 1.00E-12 Urate levels HPOID:0000079 DOID:13189 G intron GWASdb_trait 7 72863249 rs13231516 T G rs13231516 9.73E-12 Metabolite levels HPOID:0001939 DOID:655 T intron GWASdb_trait 7 72864869 rs714052 A G rs714052 3.00E-15 Triglycerides HPOID:0003119 DOID:3393|DOID:3146|DOID:2349 T intron GWASdb_trait 7 72864869 rs714052 A G rs714052 1.61E-12 Triglycerides HPOID:0003119 DOID:3393|DOID:3146|DOID:2349 T intron GWASdb_trait 7 72864869 rs714052 A G rs714052 4.38E-07 Lipid levels HPOID:0003119 DOID:3146|DOID:1287|DOID:9970 T intron GWASdb_trait 7 72864869 rs714052 A G rs714052 1.58E-10 Lipid levels HPOID:0003119 DOID:3146|DOID:1287|DOID:9970 T intron GWASdb_trait 7 72864869 rs714052 A G rs714052 2.98E-08 Lipid levels HPOID:0003119 DOID:3146|DOID:1287|DOID:9970 T intron GWASdb_trait 7 72864869 rs714052 A G rs714052 3.00E-07 Blood cell counts and other traits HPOID:0011873|HPOID:0011902|HPOID:0004352|HPOID:0004297|HPOID:0004348|HPOID:0100767|HPOID:0001909|HPOID:0002665|HPOID:0010876|HPOID:0003138|HPOID:0000077|HPOID:0003107 DOID:74|DOID:526|DOID:5844 T intron GWASdb_trait 7 72864869 rs714052 A G rs714052 3.30E-07 Blood cell counts and other traits HPOID:0011873|HPOID:0011902|HPOID:0004352|HPOID:0004297|HPOID:0004348|HPOID:0100767|HPOID:0001909|HPOID:0002665|HPOID:0010876|HPOID:0003138|HPOID:0000077|HPOID:0003107 DOID:74|DOID:526|DOID:5844 T intron GWASdb_trait 7 72864869 rs714052 A G rs714052 3.00E-06 Hypertriglyceridemia HPOID:0002155 DOID:0050527 T intron GWASdb_trait 7 72864869 rs714052 A G rs714052 1.24E-06 Caffeine consumption HPOID:0000707 NA T intron GWASdb_trait 7 72864869 rs714052 A G rs714052 1.12E-11 Metabolite levels HPOID:0001939 DOID:655 T intron GWASdb_trait 7 72864869 rs714052 A G rs714052 1.34E-36 Triglycerides HPOID:0003119 DOID:3393|DOID:3146|DOID:2349 T intron GWASdb_trait 7 72864869 rs714052 A G rs714052 3.68E-09 Urate levels HPOID:0000079 DOID:13189 T intron GWASdb_trait 7 72866616 rs34763247 A T rs34763247 9.90E-12 Metabolite levels HPOID:0001939 DOID:655 A intron GWASdb_trait 7 72868522 rs1306476 A G rs1306476 9.20E-11 Metabolite levels HPOID:0001939 DOID:655 C intron GWASdb_trait 7 72870207 rs35330527 A G rs35330527 5.56E-11 Metabolite levels HPOID:0001939 DOID:655 A intron GWASdb_trait 7 72877166 rs2074755 T C rs2074755 3.51E-06 Cardiovascular disease HPOID:0001626 DOID:1287 A intron GWASdb_trait 7 72877166 rs2074755 T C rs2074755 2.94E-07 Lipid levels HPOID:0003119 DOID:3146|DOID:1287|DOID:9970 A intron GWASdb_trait 7 72877166 rs2074755 T C rs2074755 5.10E-04 Atrial fibrillation HPOID:0005110 DOID:0050650 A intron GWASdb_trait 7 72877166 rs2074755 T C rs2074755 1.06E-11 Metabolite levels HPOID:0001939 DOID:655 A intron GWASdb_trait 7 72877166 rs2074755 T C rs2074755 3.62E-35 Triglycerides HPOID:0003119 DOID:3393|DOID:3146|DOID:2349 A intron GWASdb_trait 7 72877166 rs2074755 T C rs2074755 1.61E-09 Urate levels HPOID:0000079 DOID:13189 A intron GWASdb_trait 7 72878044 rs35797675 T G rs35797675 8.12E-13 Metabolite levels HPOID:0001939 DOID:655 T intron GWASdb_trait 7 72878645 rs12056034 A G rs12056034 5.00E-07 Triglycerides HPOID:0003119 DOID:3393|DOID:3146|DOID:2349 A intron GWASdb_trait 7 72878645 rs12056034 A G rs12056034 1.14E-11 Metabolite levels HPOID:0001939 DOID:655 A intron GWASdb_trait 7 72878645 rs12056034 A G rs12056034 2.32E-09 Urate levels HPOID:0000079 DOID:13189 A intron GWASdb_trait 7 72883106 rs62465144 T C rs62465144 6.09E-13 Metabolite levels HPOID:0001939 DOID:655 C intron GWASdb_trait 7 72885810 rs6976930 G A rs6976930 8.00E-05 Response to statin therapy HPOID:0001677 DOID:3393|DOID:423|DOID:1936 A intron GWASdb_trait 7 72885810 rs6976930 G A rs6976930 2.83E-08 Protein C levels HPOID:0003256 DOID:3756 A intron GWASdb_trait 7 72885810 rs6976930 G A rs6976930 7.61E-13 Metabolite levels HPOID:0001939 DOID:655 A intron GWASdb_trait 7 72885810 rs6976930 G A rs6976930 3.14E-11 Urate levels HPOID:0000079 DOID:13189 A intron GWASdb_trait 7 72893403 rs35695283 A G rs35695283 1.32E-11 Metabolite levels HPOID:0001939 DOID:655 A intron GWASdb_trait 7 72896395 rs7797566 A C rs7797566 1.32E-11 Metabolite levels HPOID:0001939 DOID:655 A intron GWASdb_trait 7 72901390 rs10239940 A T rs10239940 0.000000309 HDL cholesterol HPOID:0003107 DOID:14502|DOID:1461|DOID:3393 A intron GWASdb_trait 7 72901390 rs10239940 A T rs10239940 0.00000136 Triglycerides HPOID:0003119 DOID:3393|DOID:3146|DOID:2349 A intron GWASdb_trait 7 72904810 rs17145713 C T rs17145713 5.29E-10 Lipid levels HPOID:0003119 DOID:3146|DOID:1287|DOID:9970 C intron GWASdb_trait 7 72904810 rs17145713 C T rs17145713 8.00E-05 Response to statin therapy HPOID:0001677 DOID:3393|DOID:423|DOID:1936 C intron GWASdb_trait 7 72904810 rs17145713 C T rs17145713 3.00E-08 Protein C levels HPOID:0003256 DOID:3756 C intron GWASdb_trait 7 72904810 rs17145713 C T rs17145713 5.09E-13 Metabolite levels HPOID:0001939 DOID:655 C intron GWASdb_trait 7 72904810 rs17145713 C T rs17145713 1.35E-35 Triglycerides HPOID:0003119 DOID:3393|DOID:3146|DOID:2349 C intron GWASdb_trait 7 72904810 rs17145713 C T rs17145713 2.16E-11 Urate levels HPOID:0000079 DOID:13189 C intron GWASdb_trait 7 72911843 rs13244268 T C rs13244268 1.29E-11 Metabolite levels HPOID:0001939 DOID:655 T intron GWASdb_trait 7 72911843 rs13244268 T C rs13244268 2.27E-09 Urate levels HPOID:0000079 DOID:13189 T intron GWASdb_trait 7 72922233 rs13221253 A G rs13221253 7.57E-12 Metabolite levels HPOID:0001939 DOID:655 A intron GWASdb_trait 7 72934510 rs7811265 A G rs7811265 5.90E-05 Response to statin therapy HPOID:0001677 DOID:3393|DOID:423|DOID:1936 G intron GWASdb_trait 7 72934510 rs7811265 A G rs7811265 3.92E-08 Protein C levels HPOID:0003256 DOID:3756 G intron GWASdb_trait 7 72934510 rs7811265 A G rs7811265 1.57E-12 Metabolite levels HPOID:0001939 DOID:655 G intron GWASdb_trait 7 72934510 rs7811265 A G rs7811265 2.17E-10 Urate levels HPOID:0000079 DOID:13189 G intron GWASdb_trait

Disease associated variation - OMIM Ensembl_gene_ID Approved Gene Symbol MIM Number ENSG00000009954.10 BAZ1B 605681